Skip to main content
. Author manuscript; available in PMC: 2015 Jul 10.
Published in final edited form as: Clin Cancer Res. 2008 Nov 1;14(21):7095–7101. doi: 10.1158/1078-0432.CCR-08-1007

Fig. 3.

Fig. 3

Romidepsin-induced histone acetylation H3 acetylation at the (A) p15 promoter and (B) MDR1 promoter in 4 patients analyzed at 4 h after therapy compared with pre-therapy samples.